Q5127 Injection, stimufend, 0.5 milligrams
Also known as: Stimufend injection, filgrastim-sglm
Injection of Stimufend, filgrastim-sglm biosimilar per 0.5 milligram, a granulocyte-colony stimulating factor.
In Plain Language
white blood cell stimulator; neutropenia prevention
Clinical Context
Used for chemotherapy-induced neutropenia and hematologic support in cancer patients.
RVU Information
CPT Q5127 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q5127?
CPT Q5127 (Injection, stimufend, 0.5 milligrams) is a Q Codes code. Injection of Stimufend, filgrastim-sglm biosimilar per 0.5 milligram, a granulocyte-colony stimulating factor.
Is Q5127 covered by insurance?
Q5127 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for chemotherapy-induced neutropenia and hematologic support in cancer patients.
When is CPT Q5127 used?
Used for chemotherapy-induced neutropenia and hematologic support in cancer patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.